Clinical Trial Detail

NCT ID NCT04266912
Title Avelumab and M6620 for the Treatment of DDR Deficient Metastatic or Unresectable Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center
Indications

Advanced Solid Tumor

Therapies

Avelumab + Berzosertib

Age Groups: adult senior

Additional content available in CKB BOOST